Drug Search Results
More Filters [+]


Alternative Names: z-lehd-fmk
Latest Update: 2022-06-26
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CASP9 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Z-lehd-fmk

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events